With a compound annual growth rate (CAGR) of 6.1% from 2023 to 2033, the global ischemia reperfusion injury treatment market is projected to reach a value of US$ 1580 million by 2033 from a value of US$ 823.74 million in 2022. The market for ischemia reperfusion injury treatments is expanding, which can be linked to the rising incidence of illnesses like heart attacks, strokes, and organ...